Related Experiment Video
Updated: Jun 8, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Laparoendoscopic single-site surgery (LESS) prostatectomy--robotic and conventional approach
P Kumar1, S S Kommu, B J Challacombe
1Urology Centre, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.
Summary
Laparoendoscopic single-site surgery (LESS) for prostatectomy is technically feasible but presents challenges. Robotic assistance may improve ergonomics and precision, with future flexible platforms promising wider acceptance.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Laparoendoscopic single-site surgery (LESS) is an evolving minimally invasive technique.
- Prostatectomy, including radical and simple procedures, is increasingly performed using advanced surgical methods.
Purpose of the Study:
- To review preliminary advances in LESS for prostatectomy, both robot-assisted and robot-independent.
- To analyze current publications on LESS prostatectomy in animal models and human patients.
Main Methods:
- Comprehensive literature search of Embase and Medline databases (1966-2008) and urological meeting abstracts.
- Inclusion of studies on prostatectomy using keywords related to LESS, robotics, and specific surgical systems.
- Analysis of publications with no language restrictions.
Main Results:
- LESS prostatectomy, with or without robotic aid, is technically feasible but poses significant challenges.
- Robotic systems like the da Vinci Surgical System can mitigate ergonomic issues, reduce instrument clash, and enhance precision.
- Preliminary oncological control data is limited, and cosmetic improvement is the primary proven advantage.
Conclusions:
- LESS prostatectomy demonstrates technical feasibility with potential ergonomic benefits, especially with robotic assistance.
- Further advancements, including flexible robotic platforms, may enhance feasibility and acceptance of LESS for radical prostatectomy.
- Current evidence does not conclusively demonstrate advantages beyond cosmesis, pending further research on oncological outcomes.
